Sodali & Co Announces Executive Leadership Appointments
Sodali & Co (the ‘firm’ or ‘Sodali’), the leading global capital markets-centric stakeholder advisory firm, is pleased to announce four appointments to its Executive Leadership Team (ELT) under Chief Executive Officer Andrew Benett. These newly created senior roles will strengthen Sodali’s ability to respond to clients’ evolving needs with an integrated suite of shareholder, sustainability, and strategic communications advisory services delivered on a global scale.
The appointments are as follows:
Brett Clegg has been promoted to Chief Commercial Officer. Brett was previously Chairman of Sodali’s APAC region, based in the firm’s Sydney office. He specializes in advising clients on strategic communications, issues management, and capital markets transactions. Prior to Sodali, Brett spent over two decades in senior executive and editorial roles at some of Australia’s leading news brands, including The Australian Financial Review, The Australian, and The Daily Telegraph.
Aneliya Crawford has joined as Chief Partnerships Officer & Global Head of Shareholder Advisory, based in New York. Most recently, Aneliya served as the Head of Corporate Shareholder Advisory, Americas at UBS. Prior to that as Global Head of Activism and Defense at UBS, she built the shareholder activism and defense practice for the investment bank globally. Prior to UBS, Aneliya was an equity partner in the M&A group at Schulte, Roth & Zabel, co-heading one of the leading shareholder activism groups in private law. She was previously an M&A partner at Olshan Frome Wolosky.
Liz Micci has joined as Chief Client Officer & Global Head of Strategic Communications, based in New York. Lizis a proven communications executive with 25 years of experience at leading strategic communications firms. With expertise spanning corporate, crisis, and financial communications, Liz joins from FGS Global, where she held a number of leadership roles, most recently co-leading the firm’s Global Strategy and Reputation Practice and serving on the North America Executive Committee.
Nadia Krivickova has joined as Chief People Officer based in New York and Stamford, CT. Nadia joins Sodali from Forensic Risk Alliance, where she served as Chief People Officer, following nearly 20 years at AlixPartners in New York, where she led Americas People Planning and Operations, Global Strategic Staffing, and other key People roles. Before pivoting her career to HR, Nadia was a consultant in AlixPartners’ Risk Advisory practice, focusing on forensic accounting and corporate investigations.
In addition to Brett, Aneliya, Liz, and Nadia, the following Sodali leaders will sit on the newly formed Executive Leadership Team:
- Dan Wadleigh, Chief Financial Officer, who joined Sodali in 2025 after holding CFO positions at a variety of communications, advertising, and marketing firms.
- Amy Murphy, Global Head of Strategy, who joined Sodali from PwC in 2025.
- Lauren Palumbo, Chief of Staff, who previously served as Head of Operations for Sodali’s Sustainability Practice.
Andrew Benett, Chief Executive Officer of Sodali & Co, commented:
“Companies today face high-stakes decisions where financial health, stakeholder trust, governance risk, and sustainability expectations are all intertwined. At Sodali & Co, we are ideally positioned to help clients navigate these dynamics with an integrated, global approach that is unique in our industry.
The ability to attract and retain world-class talent such as Brett, Aneliya, Liz, and Nadia is both an endorsement of and an accelerant to this specialized strategy. Working together as one team, we will provide our clients with integrated expertise and bespoke advice to address complex interconnected issues, identify and capitalize on strategic opportunities, and drive successful business outcomes.Meanwhile, we will continue to invest in our unmatched capital markets data and intelligence capabilities to provide clients the differentiated insights that underpin our offering.”
These appointments come after a period of sustained growth for Sodali. The firm reported a record year the 12 months to June 30, 2025, as clients face increasingly complicated and interconnected issues including cross border M&A and shareholder activism.
ABOUT SODALI & CO
Sodali & Co is the leading global capital markets-centric stakeholder advisory firm providing a full suite of integrated shareholder, sustainability, and strategic communications advisory services. The Firm delivers clients differentiated insights, integrated expertise, and bespoke advice to address complex interconnected issues, identify and capitalize on strategic opportunities, and drive successful business outcomes. Sodali operates out of three global headquarters in New York, London, and Sydney and is supported by 12 regional offices in major financial capitals around the world. Its work is consistently recognized by leading industry rankings and awards, including being named the #1 Proxy Solicitation Firm in the Diligent Advisor Awards, #1 in Global Activism Solicitor in Bloomberg’s 2025 Activism Review, #1 in APAC & Sovereign Deals Liability Management, Top Recommended Reputation Managers in Spears500, and #4 for FTSE 350 representation in the UK corporate adviser rankings. For more information, please visit www.sodali.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260107521979/en/
Contacts
Press Contacts
Europe:
Victoria Palmer-Moore
vpm@sodali.com
+44 7725 565 545
Australia/APAC:
Jon Snowball
jon.snowball@sodali.com
+61 477 946 068
US:
Liz Micci
elizabeth.micci@sodali.com
+1 347 675 2883
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom